Table 1.
Characteristic* | All (n = 126) | Women n = 46 (37%) |
P-value | |
---|---|---|---|---|
Age, years | 53 (46–59) | 54 (46–60) | 0.32 | |
Race | Non-Hispanic white | 87 (71) | 32 (71) | 0.33 |
Black | 6 (5) | 2 (4) | ||
Hispanic | 17 (14) | 5 (11) | ||
Asian | 7 (6) | 2 (4) | ||
Other | 5 (4) | 4 (9) | ||
Etiology of liver disease | HCV | 39 (31) | 12 (26) | 0.02 |
Alcohol | 31 (25) | 8 (17) | ||
NASH/NAFLD | 9 (7) | 5 (11) | ||
AIH/PBC/PSC | 16 (13) | 11 (24) | ||
HBV | 12 (10) | 2 (4) | ||
Other | 19 (15) | 8 (17) | ||
HCC | 16 (13) | 5 (11) | 0.67 | |
Diabetes | 23 (18) | 11 (25) | 0.4 | |
Coronary Artery Disease | 5 (4) | 1 (2) | 0.5 | |
Weight, kg | 81 (69–95) | 77 (67–87) | 0.02 | |
BMI, kg/m2 | 28 (24–33) | 27 (24–32) | 0.38 | |
Admit MELD | 30 (22–36) | 30 (24–37) | 0.60 | |
Admit MELDNa | 33 (25–38) | 33 (26–38) | 0.78 | |
Laboratories at transplant | MELD | 32 (25–37) | 31 (25–36) | 0.23 |
MELDNa | 32 (26–38) | 32 (26–37) | 0.17 | |
Sodium | 137 (133–141) | 138 (135–141) | 0.07 | |
Bilirubin | 16.9 (6.3–31.2) | 18.5 (7.4–31.2) | 0.88 | |
INR | 2.3 (1.7–3.1) | 2.3 (1.7–3.0) | 0.97 | |
Creatinine | 1.8 (1.0–3.0) | 1.5 (0.9–2.2) | 0.04 | |
Albumin (g/dL) | 3.2 (2.9–3.7) | 3.4 (3.1–4.0) | 0.01 | |
Ascites | None | 25 (20) | 7 (16) | 0.56 |
Mild/moderate | 56 (44) | 20 (44) | ||
Severe | 44 (35) | 18 (40) | ||
Hepatic encephalopathy | Absent | 45 (36) | 12 (26) | 0.19 |
Altered Mood/Confusion | 47 (38) | 21 (46) | ||
Markedly Confused/Comatose | 33 (26) | 13 (28) | ||
Simultaneous liver/kidney transplant | 9 (11) | 3 (10) | 0.82 | |
Time from abdominal CT scan to transplant, days | 14 (7–30) | 19 (9–35) | 0.04 | |
Posttransplant follow-up time, years | 5.1 (2–9.8) | 4.2 (2–8.9) | 0.31 |
Median (IQR) or n (%)